199 related articles for article (PubMed ID: 36881331)
21. ROS mediated anticandidal efficacy of 3-Bromopyruvate prevents vulvovaginal candidiasis in mice model.
Jothi R; Hong ST; Enkhtsatsral M; Pandian SK; Gowrishankar S
PLoS One; 2023; 18(12):e0295922. PubMed ID: 38153954
[TBL] [Abstract][Full Text] [Related]
22. Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation.
Martinez RC; Seney SL; Summers KL; Nomizo A; De Martinis EC; Reid G
Microbiol Immunol; 2009 Sep; 53(9):487-95. PubMed ID: 19703242
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of Lactobacillus casei Shirota against both Candida auris and Candida spp. isolates that cause vulvovaginal candidiasis and are resistant to antifungals.
Paniágua AL; Correia AF; Pereira LC; de Alencar BM; Silva FBA; Almeida RM; de Medeiros Nóbrega YK
BMC Complement Med Ther; 2021 Sep; 21(1):237. PubMed ID: 34556109
[TBL] [Abstract][Full Text] [Related]
24. Vulvovaginal candidiasis: histologic lesions are primarily polymicrobial and invasive and do not contain biofilms.
Swidsinski A; Guschin A; Tang Q; Dörffel Y; Verstraelen H; Tertychnyy A; Khayrullina G; Luo X; Sobel JD; Jiang X
Am J Obstet Gynecol; 2019 Jan; 220(1):91.e1-91.e8. PubMed ID: 30595144
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
Vicariotto F; Del Piano M; Mogna L; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
[TBL] [Abstract][Full Text] [Related]
26. Emergence of Candida glabrata in vulvovaginal candidiasis should be attributed to selective pressure or virulence ability?
Nakamura-Vasconcelos SS; Fiorini A; Zanni PD; Bonfim-Mendonça PS; Godoy JR; Almeida-Apolonio AA; Consolaro MEL; Svidzinski TIE
Arch Gynecol Obstet; 2017 Sep; 296(3):519-526. PubMed ID: 28730269
[TBL] [Abstract][Full Text] [Related]
27. Bioactive compounds with antifungal activity against pathogens isolated from pregnant woman: Gallesia integrifolia (garlic wood) is a promising treatment for vulvovaginal candidiasis.
de Souza ANV; Faria MGI; da Rocha CE; Philippsen GS; Silva GCC; da Silva GR; Inumaro RS; Gonçalves JE; Gazim ZC; Wietzikoski S; Lívero FADR; Seixas FAV; Wietzikoski Lovato EC
J Ethnopharmacol; 2022 Sep; 295():115403. PubMed ID: 35643209
[TBL] [Abstract][Full Text] [Related]
28. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
[TBL] [Abstract][Full Text] [Related]
29. Spilanthol as a promising antifungal alkylamide for the treatment of vulvovaginal candidiasis.
Fabri RL; Freitas JCO; Lemos ASO; Campos LM; Diniz IOM; Pinto NCC; Silva TP; Palazzi C; Marchesini P; Monteiro C; Barbosa AF; Carvalho MG; Chedier LM; Araújo MGF; Apolônio ACM; Rocha VN; Melo RCN; Pinto PF
Med Mycol; 2021 Dec; 59(12):1210-1224. PubMed ID: 34468763
[TBL] [Abstract][Full Text] [Related]
30. Effect of the Pulsatilla decoction n-butanol extract on vulvovaginal candidiasis caused by Candida glabrata and on its virulence factors.
Zhang J; Jiang X; Shi G; Zhang H; Hu K; Wu D; Shao J; Liu T; Wang T; Wang C
Fitoterapia; 2024 Mar; 173():105825. PubMed ID: 38219843
[TBL] [Abstract][Full Text] [Related]
31. The bacterial communities in vagina of different Candida species-associated vulvovaginal candidiasis.
Chen Z; Jin J; Chen H; Chen Y; Feng S
Microb Pathog; 2023 Apr; 177():106037. PubMed ID: 36842517
[TBL] [Abstract][Full Text] [Related]
32. Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment.
Woodburn KW; Clemens LE; Jaynes J; Joubert LM; Botha A; Nazik H; Stevens DA
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451496
[TBL] [Abstract][Full Text] [Related]
33. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
[TBL] [Abstract][Full Text] [Related]
35. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections.
Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
Microb Pathog; 2022 Sep; 170():105696. PubMed ID: 35921954
[TBL] [Abstract][Full Text] [Related]
36. Antibiofilm potential of Annona muricata L. ethanolic extract against multi-drug resistant Candida albicans.
Campos LM; Silva TP; de Oliveira Lemos AS; Mendonça Diniz IO; Palazzi C; Novaes da Rocha V; de Freitas Araújo MG; Melo RCN; Fabri RL
J Ethnopharmacol; 2023 Oct; 315():116682. PubMed ID: 37263318
[TBL] [Abstract][Full Text] [Related]
37. Simulated vaginal fluid: Candida resistant strains' biofilm characterization and vapor phase of essential oil effect.
Fernandes L; Costa R; Henriques M; Rodrigues ME
J Mycol Med; 2023 Mar; 33(1):101329. PubMed ID: 36270212
[TBL] [Abstract][Full Text] [Related]
38. Anti-biofilm activity of chlorhexidine digluconate against Candida albicans vaginal isolates.
Alvendal C; Mohanty S; Bohm-Starke N; Brauner A
PLoS One; 2020; 15(9):e0238428. PubMed ID: 32941438
[TBL] [Abstract][Full Text] [Related]
39. The Antibiofilm Role of Biotics Family in Vaginal Fungal Infections.
Boahen A; Than LTL; Loke YL; Chew SY
Front Microbiol; 2022; 13():787119. PubMed ID: 35694318
[TBL] [Abstract][Full Text] [Related]
40. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
Nagashima M; Yamagishi Y; Mikamo H
J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
